Are Community Food Assistance Programs Meeting the Needs Of Food-Insecure Households in Pittsburgh\u27s North Side Neighborhoods?

Semi-structured interviews with three householders and three community food program managers were conducted to explore if food assistance programs meet the needs of residents in Pittsburgh\u27s North Side neighborhoods. Findings show that insufficient income is the main factor contributing to household food insecurity. North Side residents also have difficulty obtaining nutritious and affordable foods because fresh produce is often too expensive and supermarket food quality is considered low. Farm stands and other food access programs are well received, but only provide access to nutritious foods during the summer. Limited income and limited food access increase reliance on food pantries and Produce to People. Householders use multiple programs to meet their food needs. Householders appreciate the food programs and seem satisfied; however, responses suggest some needs are unfulfilled and householders face monotonous diets. This may not be apparent to providers because householders may mask dissatisfaction to avoid appearing unappreciative. North Side food assistance programs provide sufficient food and usually complementary food to residents, but there appears to be a lack of variety in household diets and seasonal access to fresh and nutritious foods

Physical therapy and deep brain stimulation in Parkinson’s Disease: Protocol for a pilot randomized controlled trial

Abstract Background Subthalamic nucleus deep brain stimulation (STN-DBS) reduces tremor, muscle stiffness, and bradykinesia in people with Parkinson’s Disease (PD). Walking speed, known to be reduced in PD, typically improves after surgery; however, other important aspects of gait may not improve. Furthermore, balance may worsen and falls may increase after STN-DBS. Thus, interventions to improve balance and gait could reduce morbidity and improve quality of life following STN-DBS. Physical therapy (PT) effectively improves balance and gait in people with PD, but studies on the effects of PT have not been extended to those treated with STN-DBS. As such, the efficacy, safety, and feasibility of PT in this population remain to be determined. The purpose of this pilot study is to address these unmet needs. We hypothesize that PT designed to target balance and gait impairment will be effective, safe, and feasible in this population. Methods/design Participants with PD treated with STN-DBS will be randomly assigned to either a PT or control group. Participants assigned to PT will complete an 8-week, twice-weekly PT program consisting of exercises designed to improve balance and gait. Control group participants will receive the current standard of care following STN-DBS, which does not include prescription of PT. The primary aim is to assess preliminary efficacy of PT on balance (Balance Evaluation Systems Test). A secondary aim is to assess efficacy of PT on gait (GAITRite instrumented walkway). Participants will be assessed OFF medication/OFF stimulation and ON medication/ON stimulation at baseline and at 8 and 12 weeks after baseline. Adverse events will be measured over the duration of the study, and adherence to PT will be measured to determine feasibility. Discussion To our knowledge, this will be the first study to explore the preliminary efficacy, safety, and feasibility of PT for individuals with PD with STN-DBS. If the study suggests potential efficacy, then this would justify larger trials to test effectiveness and safety of PT for those with PD with STN-DBS. Trial registration NCT03181282 (clinicaltrials.gov). Registered on 7 June 2017

Protein structural variation in computational models and crystallographic data

Normal mode analysis offers an efficient way of modeling the conformational flexibility of protein structures. Simple models defined by contact topology, known as elastic network models, have been used to model a variety of systems, but the validation is typically limited to individual modes for a single protein. We use anisotropic displacement parameters from crystallography to test the quality of prediction of both the magnitude and directionality of conformational variance. Normal modes from four simple elastic network model potentials and from the CHARMM forcefield are calculated for a data set of 83 diverse, ultrahigh resolution crystal structures. While all five potentials provide good predictions of the magnitude of flexibility, the methods that consider all atoms have a clear edge at prediction of directionality, and the CHARMM potential produces the best agreement. The low-frequency modes from different potentials are similar, but those computed from the CHARMM potential show the greatest difference from the elastic network models. This was illustrated by computing the dynamic correlation matrices from different potentials for a PDZ domain structure. Comparison of normal mode results with anisotropic temperature factors opens the possibility of using ultrahigh resolution crystallographic data as a quantitative measure of molecular flexibility. The comprehensive evaluation demonstrates the costs and benefits of using normal mode potentials of varying complexity. Comparison of the dynamic correlation matrices suggests that a combination of topological and chemical potentials may help identify residues in which chemical forces make large contributions to intramolecular coupling.Comment: 17 pages, 4 figure

Radiative cooling in collisionally and photo ionized plasmas

We discuss recent improvements in the calculation of the radiative cooling in both collisionally and photo ionized plasmas. We are extending the spectral simulation code Cloudy so that as much as possible of the underlying atomic data is taken from external databases, some created by others, some developed by the Cloudy team. This paper focuses on recent changes in the treatment of many stages of ionization of iron, and discusses its extensions to other elements. The H-like and He-like ions are treated in the iso-electronic approach described previously. Fe II is a special case treated with a large model atom. Here we focus on Fe III through Fe XXIV, ions which are important contributors to the radiative cooling of hot, 1e5 to 1e7 K, plasmas and for X-ray spectroscopy. We use the Chianti atomic database to greatly expand the number of transitions in the cooling function. Chianti only includes lines that have atomic data computed by sophisticated methods. This limits the line list to lower excitation, longer wavelength, transitions. We had previously included lines from the Opacity Project database, which tends to include higher energy, shorter wavelength, transitions. These were combined with various forms of the g-bar approximation, a highly approximate method of estimating collision rates. For several iron ions the two databases are almost entirely complementary. We adopt a hybrid approach in which we use Chianti where possible, supplemented by lines from the Opacity Project for shorter wavelength transitions. The total cooling including the lightest thirty elements differs significantly from some previous calculations

A year in the life of GW170817: the rise and fall of a structured jet from a binary neutron star merger

We present the results of our year-long afterglow monitoring of GW170817, the first binary neutron star (NS) merger detected by advanced LIGO and advanced Virgo. New observations with the Australian Telescope Compact Array (ATCA) and the Chandra X-ray Telescope were used to constrain its late-time behavior. The broadband emission, from radio to X-rays, is well-described by a simple power-law spectrum with index ~0.585 at all epochs. After an initial shallow rise ~t^0.9, the afterglow displayed a smooth turn-over, reaching a peak X-ray luminosity of ~5e39 erg/s at 160 d, and has now entered a phase of rapid decline ~t^(-2). The latest temporal trend challenges most models of choked jet/cocoon systems, and is instead consistent with the emergence of a relativistic structured jet seen at an angle of ~22 deg from its axis. Within such model, the properties of the explosion (such as its blastwave energy E_K~2E50 erg, jet width theta_c~4 deg, and ambient density n~3E-3 cm^(-3)) fit well within the range of properties of cosmological short GRBs.Comment: 11 pages, 8 figures, 2 tables, MNRAS, in press. Final version, minor changes only relative to original submission dated 21 August 201

Recent experiments on a small-angle/wide-angle X-ray scattering beam line at the ESRF

Recent results using a new combined small-angle/wide-angle X-ray scattering (SAXS/WAXS) beam line at the European Synchrotron Radiation Source (ESRF) will be presented. This beam line is specifically designed to be able to handle complicated sample environments required to perform time-resolved experiments mimicking processing conditions used in material science. Besides the attention that has been given to the interfacing of these sample environments to the beam line data acquisition system also the developments in detector technology will be discussed. The influence that a high count rate and low noise WAXS detector can have on the accuracy of experimental results in polymer crystallisation will be shown. It is shown that it is feasible to detect crystalline volume fractions as low as 10(-3)-10(-4) in polymeric systems

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.

IntroductionTofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive adult patients with RA. In this post hoc analysis, we compared efficacy and safety of tofacitinib in patients with early (disease duration <1 year) versus established (≥1 year) RA.MethodsMTX-naive patients ≥18 years with active RA received tofacitinib monotherapy (5 or 10 mg two times a day, or MTX monotherapy, in a 24-month Phase 3 trial.ResultsOf 956 patients (tofacitinib 5 mg two times a day, n=373; tofacitinib 10 mg two times a day, n=397; MTX, n=186), 54% had early RA. Baseline disease activity and functional disability were similar in both groups; radiographic damage was greater in patients with established RA. At month 24, clinical response rates were significantly greater in patients with early versus established RA in the tofacitinib 5 mg two times a day group. Both tofacitinib doses had greater effects on clinical, functional and radiographic improvements at 1 and 2 years compared with MTX, independent of disease duration. No new safety signals were observed.ConclusionsTreatment response was generally similar in early and established RA; significantly greater improvements were observed at month 24 with tofacitinib 5 mg two times a day in early versus established RA. Tofacitinib 5 and 10 mg two times a day demonstrated greater efficacy versus MTX irrespective of disease duration. No difference in safety profiles was observed between patients with early or established RA.Trial registration numberNCT01039688; Results